- Phare
- Validé par KD/KO
Anticorps Polyclonal de lapin anti-Glypican 1
Glypican 1 Polyclonal Antibody for WB, IP, IHC, ELISA
Hôte / Isotype
Lapin / IgG
Réactivité testée
Humain, rat, souris
Applications
WB, IP, IF, IHC, CoIP, ELISA
Conjugaison
Non conjugué
N° de cat : 16700-1-AP
Synonymes
Galerie de données de validation
Applications testées
Résultats positifs en WB | cellules HepG2, |
Résultats positifs en IP | cellules BxPC-3, |
Résultats positifs en IHC | tissu de cancer du pancréas humain, il est suggéré de démasquer l'antigène avec un tampon de TE buffer pH 9.0; (*) À défaut, 'le démasquage de l'antigène peut être 'effectué avec un tampon citrate pH 6,0. |
Dilution recommandée
Application | Dilution |
---|---|
Western Blot (WB) | WB : 1:500-1:1000 |
Immunoprécipitation (IP) | IP : 0.5-4.0 ug for 1.0-3.0 mg of total protein lysate |
Immunohistochimie (IHC) | IHC : 1:50-1:500 |
It is recommended that this reagent should be titrated in each testing system to obtain optimal results. | |
Sample-dependent, check data in validation data gallery |
Applications publiées
KD/KO | See 2 publications below |
WB | See 11 publications below |
IHC | See 9 publications below |
IF | See 2 publications below |
CoIP | See 1 publications below |
Informations sur le produit
16700-1-AP cible Glypican 1 dans les applications de WB, IP, IF, IHC, CoIP, ELISA et montre une réactivité avec des échantillons Humain, rat, souris
Réactivité | Humain, rat, souris |
Réactivité citée | Humain, souris |
Hôte / Isotype | Lapin / IgG |
Clonalité | Polyclonal |
Type | Anticorps |
Immunogène | Glypican 1 Protéine recombinante Ag10095 |
Nom complet | glypican 1 |
Masse moléculaire calculée | 558 aa, 62 kDa |
Poids moléculaire observé | 65 kDa |
Numéro d’acquisition GenBank | BC051279 |
Symbole du gène | GPC1 |
Identification du gène (NCBI) | 2817 |
Conjugaison | Non conjugué |
Forme | Liquide |
Méthode de purification | Purification par affinité contre l'antigène |
Tampon de stockage | PBS avec azoture de sodium à 0,02 % et glycérol à 50 % pH 7,3 |
Conditions de stockage | Stocker à -20°C. Stable pendant un an après l'expédition. L'aliquotage n'est pas nécessaire pour le stockage à -20oC Les 20ul contiennent 0,1% de BSA. |
Informations générales
Glypicans are a family of HSPGs that are attached to the cell membrane by a glycosyl-phosphatidylinositol anchor. Glypicans are considered to have the ability to modulate the activities of HBGFs. The expression of glypicans is regulated temporally and spatially during development, suggesting they are involved in development and morphogenesis. To date, six glypicans (GPC1 to GPC6) have been identified in mammals. GPC1 is most ubiquitously expressed in adult tissues. GPC1 promotes efficient signaling by HBGFs and plays a critical role in cell growth and differentiation. GPC1 is involved in tumorigenesis and angiogenesis, and is frequently overexpressed in several types of tumors including pancreatic carcinoma, breast cancer and glioma.
Protocole
Product Specific Protocols | |
---|---|
WB protocol for Glypican 1 antibody 16700-1-AP | Download protocol |
IHC protocol for Glypican 1 antibody 16700-1-AP | Download protocol |
IP protocol for Glypican 1 antibody 16700-1-AP | Download protocol |
Standard Protocols | |
---|---|
Click here to view our Standard Protocols |
Publications
Species | Application | Title |
---|---|---|
Nat Commun Decoding non-canonical mRNA decay by the endoplasmic-reticulum stress sensor IRE1α | ||
Matrix Biol miR-324-5p is up regulated in end-stage osteoarthritis and regulates Indian Hedgehog signalling by differing mechanisms in human and mouse.
| ||
Mod Pathol Glypican-1 immunohistochemistry does not separate mesothelioma from pulmonary adenocarcinoma. | ||
Mod Pathol Glypican-1 immunohistochemistry is a novel marker to differentiate epithelioid mesothelioma from lung adenocarcinoma. | ||
Front Cell Dev Biol The Glypican-1/HGF/C-Met and Glypican-1/VEGF/VEGFR2 Ternary Complexes Regulate Hair Follicle Angiogenesis. | ||
Transl Lung Cancer Res Glypican-1 is a novel immunohistochemical marker to differentiate poorly differentiated squamous cell carcinoma from solid predominant adenocarcinoma of the lung. |
Avis
The reviews below have been submitted by verified Proteintech customers who received an incentive forproviding their feedback.
FH Vishwa Jeet (Verified Customer) (11-09-2017) | Recently, our publication has been accepted in Modern Pathology.
|